| Data to be extracted | Data |
---|---|---|
Population | Age range | Â |
Diagnostic modality for hydrocephalus/CSF hypertension | Â | |
Diagnostic modality for underlying aetiology | Â | |
CD4+ cell count range (for each underlying aetiology) | Â | |
Country population derived from | Â | |
Severity of disease at baseline (using GCS, palur grade, MRC scale, GOS or mRS) for each underlying aetiology | Â | |
Communicating or non-communicating hydrocephalus | Â | |
Intervention | Primary VPS or following EVD | Â |
Catheter type (plain silicon, antibiotic impregnated, silver impregnated) | Â | |
Comparison intervention | Description of intervention | Â |
Frequency of intervention | Â | |
Outcome (for each underlying aetiology and intervention) | Survival at 1, 6 and 12Â months | Â |
Causes of death at 1, 6 and 12Â months | Â | |
Rate of shunt failure at 1, 6 and 12 months | Â | |
Rates of complication at 1, 6 and 12 months | Â | |
Validated outcome measure at 1, 6 and 12Â months | Â |